The past couple of years have been challenging for biotech companies. At #JPM2025, investors were looking for two things: Phase II results, and a #DigitalTransformation story that showed how #AI, #automation and advanced analytics would be used to advance early stage programs into the clinic.

The past couple of years have been challenging for biotech companies. At #JPM2025, investors were looking for two things: Phase II results, and a Digital Transformation story that showed how #AI, #automation and advanced analytics would be used to advance early stage programs into the clinic.

Our key takeaways from #JPM2025:

🤝 M&As rise

🤖 #AI boosts drug discovery

🌎 Chinese #Innovation gains global recognition

Discover more insights 👉 bit.ly/4htaweG

#HealthcareInnovation, #AI, #OnMyHorizon

MaaT Pharma : Pioneering microbiome-driven therapy as new pillar in oncology | CEO Hervé Affagard discusses MaaT Pharma's new approach to microbiome-driven therapies and impressive Phase 3 results in treating acute Graft-versus Host disease.

Last month at #JPM2025, our CEO, Hervé Affagard, MBA, Eng., joined Fierce Pharma's Rebecca Willumson for an exclusive interview, highlighting the importance of advancing innovation for patients facing #GvHD.

📺 𝗪𝗮𝘁𝗰𝗵 𝘁𝗵𝗲 𝗳𝘂𝗹𝗹 𝗶𝗻𝘁𝗲𝗿𝘃𝗶𝗲𝘄: www.fiercepharma.com/sponsored/ma...

Massive Bio Recognized by White House Cancer Moonshot for First-of-Their-Kind Pre-Screening Hubs and AI-Powered Trial Matching, Launches $15 Million Initiative at J.P. Morgan 2025.

🌎 Learn more: bit.ly/4aPhQPd

#CancerMoonshot #AIinHealthcare #JPM2025

A large group of women wearing items of pink clothing

Two women, wearing pink and waving at the camera

#FBF: Revisiting "In the Pink" at #JPM2025, a celebration of the contributions of women leaders in biotech & pharma—and their allies. Can you spot CBO Neela Patel & VP Cindy Yee in the #SeaOfPink?

Thanks to Biotech CEO Sisterhood, #Breaking7% & @cooleyllp.bsky.social for sponsoring! #ProjectMirror

Can the Private Sector Serve Up Sufficient Health Media to Compensate for Public Sector Gaps? - HealthPopuli.com In researching several .gov websites from last Monday 20th January 2025, I had an ongoing frustrating user experience in being faced with “404 Error” messages like this one from WhiteHouse.gov. “Presi...

Can private sector serve up sufficient #healthmedia to compensate for public sector gaps? Reflections on repeated #404Error messages from #publichealth govt websites on #CDC #NIH & WhiteHouse.gov (looking for a Jill Biden speech on #womenshealth at #JPM2025)

bit.ly/3Q0cZ4h

#hcsm #healthliteracy

Digging out from #JPM2025?

ICYMI, I highly recommend the Jan. 23 BioCentury Show podcast where my colleague Steve Usdin discusses what he is hearing in DC: FDA, FTC, NIH, IRA/drug pricing, Biosecure/China. No one is better sourced in DC than Steve.

🎧: podcasts.apple.com/us/podcast/e...

Enjoyed recording these "hot takes" from startup founders and friends on today’s hot topics in health! 🩺🎥🔥
#JPM2025 #Healthcare #MITCNC #DiscoveryEngines

youtube.com/shorts/7Kn_C...

BioCentury-BayHelix East-West Summit In 2025, BioCentury, BayHelix and Insights Partner McKinsey & Company return to Singapore for the 4th East-West Biopharma Summit – a CEO and investor conference focused on Asia’s emerging Arc of Innov...

If you attended #JPM2025, you heard about the biopharma innovation coming out of China/Asia - from cross-border deals to the Asia Newco Model.

👀 The best way to continue the discussions? See it for yourself.

✅ Register for the 4th East-West Biopharma Summit: www.BioCenturyEastWest.com

Hot topic: JPM shines bright amid the January gloom – Optimum Strategic Communications

Reflections on a busy week in San Fran at #JPM2025!
🌞 Mood upbeat – maybe it was the sunshine, but there was cautious optimism in the air!
💰 Big deal making and major financing continues.
🧪 Oncology, diabetes and obesity, and women’s health are hot areas for 2025 www.optimumcomms.com/hot-topic-jp...

PitchBook analysts share their #JPM2025 takeaways, including the progression of disease diagnostics such as #MRD, noting Foresight Diagnostics as leading the way. Catch that around minute 26: bit.ly/42mBTCl #JPM25 #HealthcareInvestment #Diagnostics #Cancer

Philly’s big Q4: The region saw $1B in VC investment last quarter alone Capital is flowing again, but deal count is relatively low: More than half the year-end funding went to a single company.

The news about Philadelphia’s VC market echoes much of the conversation at #JPM2025. Capital is flowing again as investors seek out strong companies & lower deal counts -- ‘quality over quantity.’ This reflects growing optimism in #lifesciences & #biotech. bit.ly/4g2Ta6X

Recharged by the inspiring discussions with current and prospective partners at #JPM2025. Our industry undoubtedly has flaws but there are a lot of great people at the helm seeking to make a difference in drug discovery and healthcare.
Now back to the bitter cold week ahead in Boston…

GLP-1s and Brian Thompson’s killing loom large at top health-care conference This year's JPMorgan health-care conference took place a month after UnitedHealthcare CEO Brian Thompson was fatally shot in New York City.

New: Perhaps unsurprisingly, generative AI, GLP-1s and the incoming Trump administration were big themes at #JPM2025.

But in many ways, the shooting of UHC CEO Brian Thompson was the true undercurrent of the conference this year.

Here's what health execs had to say:
www.cnbc.com/2025/01/18/g...

I am proud to work at a mission-driven company providing leading technology to people with diabetes. Our CEO shared what we’re up to at #JPM2025 this week. Check it out: s201.q4cdn.com/452214269/fi... #Insulet #Omnipod #TeamInsulet #Diabetes #DiabetesCare #T1D #T2D #JPM25 #medsky

My list of JP Morgan Healthcare posts so far. #JPM25 #JPM2025

Takeaways from JPM Healthcare Conf 2025 #JPM2025 For having survived the past two years of biotech winter and current political uncertainties, the crowd was pretty cautiously optimistic for dealflow to recover. And yes, the word “agentic” AI should have been a drinking game.🧵👇

Great week in SF at #JPM2025 with @ceclindgren.bsky.social chatting partnerships and impact in women’s health. Aneira Health was of course the toast of the town! More broadly, amazing energy in this space - big increase since last year even! 🚀

Homeward bound. Farewell city by the bay and #JPM2025

Investor panel at JPM 2025: ​Elena Itskovich, PhD - Nest Catalyst Ventures Founder and GP. ​Alok Taki, PhD - Vibe Bio Co-founder and CEO ​Manuel Grossman - Amino Collective General Partner ​Omri Amirav-Drory, PhD - NFX Bio General Partner

Enjoyed our discussion on the investor panel yesterday at #JPM2025. Many thanks to Elena Itskovich, PhD - Nest Catalyst Ventures Founder + GP, Alok Tayi, PhD - Vibe Bio Co-founder + CEO, Manuel Grossmann - Amino Collective General Partner, and Omri Drory, Phs - NFX Bio General Partner. #biotech

Welcome! You are invited to join a webinar: JPM Healthcare Conference Review. After registering, you will receive a confirmation email about joining the webinar. As is biopharma tradition, many of the industry’s movers and shakers will descend on San Francisco’s Union Square in mid-January to attend the JP Morgan Healthcare Conference — a key "scene-setting" e...

What will shape the #pharma and #biotech narrative in 2025?

If you couldn't make the annual JP Morgan Healthcare Conference this year to find out, then tune in today (January 16) for @firstwordgroup.bsky.social's review of the event. Sign up here us02web.zoom.us/webinar/regi... #JPM25 #JPM2025

Next up Nick Edwards w/ potato.ai @ HomeLab Demo Day @ #JPM2025
Imagine a world where we have 300,000,000 AI scientists. Building infrastructure and tools for autonomous science.

Devacell presenting at HomeLab Demo Day @ #JPM2025.
Gene Therapy Delivery

Checked in and ready to go at HomeLab Demo Day @ #JPM2025

This morning, our CEO Jake Chabon presented at #JPM2025. It was great to connect with industry leaders and share our groundbreaking work on ultra-sensitive minimal residual disease (MRD) detection.

Learn more about Foresight and what's on the horizon for 2025: foresight-dx.com/press_releas...

Drugmakers tout limits of IRA impact ahead of next negotiation round Johnson & Johnson, AstraZeneca and Pfizer leaders reiterated during the JP Morgan Healthcare Conference that the federal government’s price negotiations still won’t have a material effect on their bot...

At #JPM2025, J&J, AstraZeneca, and Pfizer leaders reiterated that federal price negotiations won’t materially affect their bottom lines, affirming confidence in growth.

🎙On the latest episode of #RunningThroughWalls, Nimish Shah talks to CEO of Spyre Therapeutics Cameron Turtle about what’s ahead for their most promising molecules in 2025 and his perspective on building collaborative teams and Boards. Listen here: vnrk.co/3PAJllS #JPM2025

Tomorrow join NTI | bio at #JPM2025 panel on how political shifts and biological risks impact todays #healthtech, lead by Michelle McMurry-Heath, with Emma Wheatley of @cepivaccines.bsky.social, @jennifernuzzo.bsky.social, and @jaimeyassif.bsky.social. at 7:30 AM PT

RSVP
www.nti.org/events/can-t...

GVX Venture Studio Launches FusionCare.AI: A One-Stop Shop for Obesity Care at the Future and Health Executive Summit at JPM 2025 - MedCity News Combining AI-driven insights with tailored care pathways, patients gain access to health coaches, psychologists, and treatment plans, while providers benefit from workflow optimization.

GVX Venture Studio Launches #FusionCareAI: A One-Stop Shop for Obesity Care at the Future & Health Executive Summit at #JPM2025. Learn more ⬇️

#AIInHealthcare #HealthStartup #Obesity #sponsored